메뉴 건너뛰기




Volumn 12, Issue 11, 2015, Pages 639-648

Keys to long-term care of the liver transplant recipient

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; ORAL ANTIDIABETIC AGENT; THIAZIDE DIURETIC AGENT; VITAMIN D;

EID: 84946494636     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2015.172     Document Type: Review
Times cited : (47)

References (84)
  • 1
    • 84884512187 scopus 로고    scopus 로고
    • The evolution of liver transplantation during 3 decades: Analysis of 5347 consecutive liver transplants at a single center
    • Agopian, V. G., et al. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann. Surg. 258, 409-421 (2013
    • (2013) Ann. Surg , vol.258 , pp. 409-421
    • Agopian, V.G.1
  • 2
    • 84904735306 scopus 로고    scopus 로고
    • Chronic kidney disease and associated mortality after liver transplantation-A time-dependent analysis using measured glomerular filtration rate
    • Allen, A. M., et al. Chronic kidney disease and associated mortality after liver transplantation-A time-dependent analysis using measured glomerular filtration rate. J. Hepatol. 61, 286-292 (2014
    • (2014) J. Hepatol , vol.61 , pp. 286-292
    • Allen, A.M.1
  • 3
    • 75449100949 scopus 로고    scopus 로고
    • Minimal but significant improvement in survival for non-hepatitis c related adult liver transplant patients beyond the one-year posttransplant mark
    • McCaughan, G. W., Shackel, N. A., Strasser, S. I., Dilworth, P., & Tang, P. Minimal but significant improvement in survival for non-hepatitis C related adult liver transplant patients beyond the one-year posttransplant mark. Liver Transpl. 16, 130-137 (2010
    • (2010) Liver Transpl , vol.16 , pp. 130-137
    • McCaughan, G.W.1    Shackel, N.A.2    Strasser, S.I.3    Dilworth, P.4    Tang, P.5
  • 5
    • 84921446556 scopus 로고    scopus 로고
    • Differences in long-Term survival among liver transplant recipients and the general population: A population-based nordic study
    • Aberg, F., et al. Differences in long-Term survival among liver transplant recipients and the general population: A population-based nordic study. Hepatology 61, 668-677 (2015
    • (2015) Hepatology , vol.61 , pp. 668-677
    • Aberg, F.1
  • 6
    • 80053581540 scopus 로고    scopus 로고
    • Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States
    • Charlton, M. R., et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 141, 1249-1253 (2011
    • (2011) Gastroenterology , vol.141 , pp. 1249-1253
    • Charlton, M.R.1
  • 7
    • 77952902738 scopus 로고    scopus 로고
    • Evolution of causes and risk factors for mortality post liver transplant: Results of the niddk long term follow-up study
    • Watt, K., Pedersen, R., Kremers, W., Heimbach, J., & Charlton, M. Evolution of causes and risk factors for mortality post liver transplant: results of the NIDDK Long Term Follow-up Study. Am. J. Transplant. 10, 1-8 (2010
    • (2010) Am. J. Transplant , vol.10 , pp. 1-8
    • Watt, K.1    Pedersen, R.2    Kremers, W.3    Heimbach, J.4    Charlton, M.5
  • 8
    • 84922879130 scopus 로고    scopus 로고
    • Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis c virus infection after liver transplantation
    • Charlton, M., et al. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. Gastroenterology 148, 108-117 (2015
    • (2015) Gastroenterology , vol.148 , pp. 108-117
    • Charlton, M.1
  • 9
    • 84919360641 scopus 로고    scopus 로고
    • An interferon-free antiviral regimen for hcv after liver transplantation
    • Kwo, P. Y., et al. An interferon-free antiviral regimen for HCV after liver transplantation. N. Engl. J. Med. 371, 2375-2382 (2014
    • (2014) N. Engl. J. Med , vol.371 , pp. 2375-2382
    • Kwo, P.Y.1
  • 10
    • 84942474016 scopus 로고    scopus 로고
    • Follow-up imaging after liver transplantation should take into consideration primary hepatocellular carcinoma characteristics
    • Burgio, M. D., et al. Follow-up imaging after liver transplantation should take into consideration primary hepatocellular carcinoma characteristics. Transplantation 99, 1613-1618 (2015
    • (2015) Transplantation , vol.99 , pp. 1613-1618
    • Burgio, M.D.1
  • 11
    • 84922447696 scopus 로고    scopus 로고
    • Post-Transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree
    • Pecchi, A., et al. Post-Transplantation hepatocellular carcinoma recurrence: patterns and relation between vascularity and differentiation degree. World J. Hepatol. 7, 276-284 (2015
    • (2015) World J. Hepatol , vol.7 , pp. 276-284
    • Pecchi, A.1
  • 12
    • 57849169437 scopus 로고    scopus 로고
    • Risk of malignant neoplasms after liver transplantation: A population-based study
    • Aberg, F., Pukkala, E., Hockerstedt, K., Sankila, R., & Isoniemi, H. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl. 14, 1428-1436 (2008
    • (2008) Liver Transpl , vol.14 , pp. 1428-1436
    • Aberg, F.1    Pukkala, E.2    Hockerstedt, K.3    Sankila, R.4    Isoniemi, H.5
  • 13
    • 84865583111 scopus 로고    scopus 로고
    • Posttransplant metabolic syndrome in children and adolescents after liver transplantation: A systematic review
    • Rothbaum Perito, E., Lau, A., Rhee, S., Roberts, J. P., & Rosenthal, P. Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review. Liver Transpl. 18, 1009-1028 (2012
    • (2012) Liver Transpl , vol.18 , pp. 1009-1028
    • Rothbaum Perito, E.1    Lau, A.2    Rhee, S.3    Roberts, J.P.4    Rosenthal, P.5
  • 14
    • 33746895406 scopus 로고    scopus 로고
    • Current issues in pediatric transplantation
    • Kelly, D. A. Current issues in pediatric transplantation. Pediatr. Transplant. 10, 712-720 (2006
    • (2006) Pediatr. Transplant , vol.10 , pp. 712-720
    • Kelly, D.A.1
  • 15
    • 0034853111 scopus 로고    scopus 로고
    • Analysis of causes of death in liver transplant recipients who survived more than 3 years
    • Pruthi, J., et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl. 7, 811-815 (2001
    • (2001) Liver Transpl , vol.7 , pp. 811-815
    • Pruthi, J.1
  • 16
    • 0034969097 scopus 로고    scopus 로고
    • Late mortality after orthotopic liver transplantation
    • Rabkin, J. M., et al. Late mortality after orthotopic liver transplantation. Am. J. Surg. 181, 475-479 (2001
    • (2001) Am. J. Surg , vol.181 , pp. 475-479
    • Rabkin, J.M.1
  • 17
    • 0035189008 scopus 로고    scopus 로고
    • De novo malignancies after liver transplantation: A major cause of late death
    • Fung, J. J., et al. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl. 7, S109-S118 (2001
    • (2001) Liver Transpl , vol.7 , pp. S109-S118
    • Fung, J.J.1
  • 18
    • 84886798020 scopus 로고    scopus 로고
    • Incidence and long-Term risk of de novo malignancies after liver transplantation with implications for prevention and detection
    • Schrem, H., et al. Incidence and long-Term risk of de novo malignancies after liver transplantation with implications for prevention and detection. Liver Transpl. 19, 1252-1261 (2013
    • (2013) Liver Transpl , vol.19 , pp. 1252-1261
    • Schrem, H.1
  • 19
    • 70649096162 scopus 로고    scopus 로고
    • Probability and mortality of de novo malignancy after liver transplantation: Results of the multicentered prospective niddk long term database
    • Watt, K., Pedersen, R., Heimbach, J., Kremers, W., & Gores, G. Probability and mortality of de novo malignancy after liver transplantation: results of the multicentered, prospective NIDDK long term database. Gastroenterology 137, 2010-2017 (2009
    • (2009) Gastroenterology , vol.137 , pp. 2010-2017
    • Watt, K.1    Pedersen, R.2    Heimbach, J.3    Kremers, W.4    Gores, G.5
  • 20
    • 25144490181 scopus 로고    scopus 로고
    • Nonmelanoma skin cancer after liver transplantation study of risk factors
    • Herrero, J. I., et al. Nonmelanoma skin cancer after liver transplantation. Study of risk factors. Liver Transpl. 11, 1100-1106 (2005
    • (2005) Liver Transpl , vol.11 , pp. 1100-1106
    • Herrero, J.I.1
  • 21
    • 24644495221 scopus 로고    scopus 로고
    • Post-Transplant lymphoproliferative disorders (ptld) after solid organ transplantation
    • Taylor, A. L., Marcus, R., & Bradley, J. A. Post-Transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit. Rev. Oncol. Hematol. 56, 155-167 (2005
    • (2005) Crit. Rev. Oncol. Hematol , vol.56 , pp. 155-167
    • Taylor, A.L.1    Marcus, R.2    Bradley, J.A.3
  • 22
    • 84889088336 scopus 로고    scopus 로고
    • Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: A systematic review and meta-Analysis
    • Singh, S., Edakkanambeth Varayil, J., Loftus, E. V., Jr &Talwalkar, J. A. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-Analysis. Liver Transpl. 19, 1361-1369 (2013
    • (2013) Liver Transpl , vol.19 , pp. 1361-1369
    • Singh, S.1    Edakkanambeth Varayil, J.2    Loftus, E.V.3    Talwalkar, J.A.4
  • 23
    • 80055062562 scopus 로고    scopus 로고
    • Cancer surveillance in patients with primary sclerosing cholangitis
    • Razumilava, N., Gores, G. J., & Lindor, K. D. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54, 1842-1852 (2011
    • (2011) Hepatology , vol.54 , pp. 1842-1852
    • Razumilava, N.1    Gores, G.J.2    Lindor, K.D.3
  • 25
    • 84855558441 scopus 로고    scopus 로고
    • Malignancies and mortality in 200 patients with primary sclerosering cholangitis: A long-Term single-centre study
    • Fevery, J., et al. Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-Term single-centre study. Liver Int. 32, 214-222 (2012
    • (2012) Liver Int , vol.32 , pp. 214-222
    • Fevery, J.1
  • 26
    • 84963717809 scopus 로고    scopus 로고
    • U.S. Preventive Services Task Force online
    • U.S. Preventive Services Task Force. Final Recommendation Statement Lung Cancer: Screening [online], http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lung-cancer-screening (2013
    • (2013) Final Recommendation Statement Lung Cancer: Screening
  • 27
    • 84877961632 scopus 로고    scopus 로고
    • Results of initial low-dose computed tomographic screening for lung cancer
    • Church, T. R., et al. Results of initial low-dose computed tomographic screening for lung cancer. N. Engl. J. Med. 368, 1980-1991 (2013
    • (2013) N. Engl. J. Med , vol.368 , pp. 1980-1991
    • Church, T.R.1
  • 28
    • 84887583273 scopus 로고    scopus 로고
    • Lung cancer screening with low-radiation dose computed tomography after liver transplantation
    • Herrero, J. I., et al. Lung cancer screening with low-radiation dose computed tomography after liver transplantation. Ann. Transplant. 18, 587-592 (2013
    • (2013) Ann. Transplant , vol.18 , pp. 587-592
    • Herrero, J.I.1
  • 29
    • 84868206497 scopus 로고    scopus 로고
    • Burden of de novo malignancy in the liver transplant recipient
    • Chandok, N., & Watt, K. D. Burden of de novo malignancy in the liver transplant recipient. Liver Transpl. 18, 1277-1289 (2012
    • (2012) Liver Transpl , vol.18 , pp. 1277-1289
    • Chandok, N.1    Watt, K.D.2
  • 30
    • 84861468776 scopus 로고    scopus 로고
    • Screening of de novo tumors after liver transplantation
    • Herrero, J. I. Screening of de novo tumors after liver transplantation. J. Gastroenterol. Hepatol. 27, 1011-1016 (2012
    • (2012) J. Gastroenterol. Hepatol , vol.27 , pp. 1011-1016
    • Herrero, J.I.1
  • 31
    • 1942502241 scopus 로고    scopus 로고
    • De novo internal neoplasms after liver transplantation: Increased risk and aggressive behavior in recent years?
    • Benlloch, S., et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am. J. Transplant. 4, 596-604 (2004
    • (2004) Am. J. Transplant , vol.4 , pp. 596-604
    • Benlloch, S.1
  • 32
    • 70349202958 scopus 로고    scopus 로고
    • Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients
    • Finkenstedt, A., et al. Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am. J. Transplant. 9, 2355-2361 (2009
    • (2009) Am. J. Transplant , vol.9 , pp. 2355-2361
    • Finkenstedt, A.1
  • 34
  • 35
    • 84876887552 scopus 로고    scopus 로고
    • De novo cancer-related death in australian liver and cardiothoracic transplant recipients
    • Na, R., et al. De novo cancer-related death in Australian liver and cardiothoracic transplant recipients. Am. J. Transplant. 13, 1296-1304 (2013
    • (2013) Am. J. Transplant , vol.13 , pp. 1296-1304
    • Na, R.1
  • 36
    • 84857582343 scopus 로고    scopus 로고
    • Cumulative risk of cardiovascular events after orthotopic liver transplantation
    • Albeldawi, M., et al. Cumulative risk of cardiovascular events after orthotopic liver transplantation. Liver Transpl. 18, 370-375 (2012
    • (2012) Liver Transpl , vol.18 , pp. 370-375
    • Albeldawi, M.1
  • 37
    • 84933512267 scopus 로고    scopus 로고
    • Cardiovascular disease after liver transplantation when, what and who is at risk
    • Fussner, L. A., et al. Cardiovascular disease after liver transplantation. When, what and who is at risk. Liver Transpl. 21, 889-896 (2015
    • (2015) Liver Transpl , vol.21 , pp. 889-896
    • Fussner, L.A.1
  • 38
    • 79251488789 scopus 로고    scopus 로고
    • Metabolic syndrome in liver transplant recipients: Prevalence, risk factors, and association with cardiovascular events
    • Laish, I., et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 17, 15-22 (2011
    • (2011) Liver Transpl , vol.17 , pp. 15-22
    • Laish, I.1
  • 39
    • 57849130369 scopus 로고    scopus 로고
    • Metabolic syndrome in liver transplantation: Relation to etiology and immunosuppression
    • Bianchi, G., Marchesini, G., Marzocchi, R., Pinna, A., & Zoli, M. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl. 4, 1648-1654 (2008
    • (2008) Liver Transpl , vol.4 , pp. 1648-1654
    • Bianchi, G.1    Marchesini, G.2    Marzocchi, R.3    Pinna, A.4    Zoli, M.5
  • 40
    • 34548190764 scopus 로고    scopus 로고
    • Metabolic syndrome in liver transplant recipients: Prevalence and association with cardiovascular events
    • Laryea, M., et al. Metabolic syndrome in liver transplant recipients: prevalence and association with cardiovascular events. Liver Transpl. 13, 1109-1114 (2007
    • (2007) Liver Transpl , vol.13 , pp. 1109-1114
    • Laryea, M.1
  • 41
    • 84906092120 scopus 로고    scopus 로고
    • Effect of a physical exercise program on the functional capacity of liver transplant patients
    • Garcia, A. M., Veneroso, C. E., Soares, D. D., Lima, A. S., & Correia, M. I. Effect of a physical exercise program on the functional capacity of liver transplant patients. Transplant. Proc. 46, 1807-1808 (2014
    • (2014) Transplant. Proc , vol.46 , pp. 1807-1808
    • Garcia, A.M.1    Veneroso, C.E.2    Soares, D.D.3    Lima, A.S.4    Correia, M.I.5
  • 42
    • 0031926495 scopus 로고    scopus 로고
    • Weight change and obesity after liver transplantation: Incidence and risk factors
    • Everhart, J. E., et al. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl. Surg. 4, 285-296 (1998
    • (1998) Liver Transpl. Surg , vol.4 , pp. 285-296
    • Everhart, J.E.1
  • 43
    • 20344389164 scopus 로고    scopus 로고
    • Weight gain and obesity after liver transplantation
    • Richards, J., Gunson, B., Johnson, J., & Neuberger, J. Weight gain and obesity after liver transplantation. Transpl. Int. 18, 461-466 (2005
    • (2005) Transpl. Int , vol.18 , pp. 461-466
    • Richards, J.1    Gunson, B.2    Johnson, J.3    Neuberger, J.4
  • 44
    • 84904408875 scopus 로고    scopus 로고
    • Prospective evaluation of metabolic syndrome and its components among long-Term liver recipients
    • Anastacio, L. R., et al. Prospective evaluation of metabolic syndrome and its components among long-Term liver recipients. Liver Int. 34, 1094-1101 (2014
    • (2014) Liver Int , vol.34 , pp. 1094-1101
    • Anastacio, L.R.1
  • 45
    • 33750580407 scopus 로고    scopus 로고
    • Orlistat treatment is safe in overweight and obese liver transplant recipients: A prospective, open label trial
    • Cassiman, D., et al. Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial. Transpl. Int. 19, 1000-1005 (2006
    • (2006) Transpl. Int , vol.19 , pp. 1000-1005
    • Cassiman, D.1
  • 46
    • 84873083982 scopus 로고    scopus 로고
    • Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease
    • Heimbach, J. K., et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am. J. Transplant. 13, 363-368 (2013
    • (2013) Am. J. Transplant , vol.13 , pp. 363-368
    • Heimbach, J.K.1
  • 47
    • 84889095877 scopus 로고    scopus 로고
    • Gastric bypass after liver transplantation
    • Al-Nowaylati, A. R., et al. Gastric bypass after liver transplantation. Liver Transpl. 19, 1324-1329 (2013
    • (2013) Liver Transpl , vol.19 , pp. 1324-1329
    • Al-Nowaylati, A.R.1
  • 48
    • 84871947219 scopus 로고    scopus 로고
    • Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation
    • Lin, M. Y., et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg. Endosc. 27, 81-85 (2013
    • (2013) Surg. Endosc , vol.27 , pp. 81-85
    • Lin, M.Y.1
  • 49
    • 77449144719 scopus 로고    scopus 로고
    • Long-Term outcomes of liver transplantation: Diabetes mellitus
    • Pageaux, G. P., Faure, S., Bouyabrine, H., Bismuth, M., & Assenat, E. Long-Term outcomes of liver transplantation: diabetes mellitus. Liver Transpl. 15 (Suppl 2), S79-S82 (2009
    • (2009) Liver Transpl , vol.15 , pp. S79-S82
    • Pageaux, G.P.1    Faure, S.2    Bouyabrine, H.3    Bismuth, M.4    Assenat, E.5
  • 50
    • 84866268783 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American diabetes association ada and the european association for the study of diabetes (easd
    • Inzucchi, S. E., et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes care 35, 1364-1379 (2012
    • (2012) Diabetes Care , vol.35 , pp. 1364-1379
    • Inzucchi, S.E.1
  • 51
    • 84938196381 scopus 로고    scopus 로고
    • Emerging treatments for post-Transplantation diabetes mellitus
    • Jenssen, T., & Hartmann, A. Emerging treatments for post-Transplantation diabetes mellitus. Nat. Rev. Nephrol. 11, 465-477 (2015
    • (2015) Nat. Rev. Nephrol , vol.11 , pp. 465-477
    • Jenssen, T.1    Hartmann, A.2
  • 52
    • 84893549987 scopus 로고    scopus 로고
    • 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (jnc 8
    • James, P. A., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311, 507-520 (2014
    • (2014) JAMA , vol.311 , pp. 507-520
    • James, P.A.1
  • 54
    • 0023748380 scopus 로고
    • Increased cyclosporine blood concentrations due to verapamil administration
    • Maggio, T. G., & Bartels, D. W. Increased cyclosporine blood concentrations due to verapamil administration. Drug Intell. Clin. Pharm. 22, 705-707 (1988
    • (1988) Drug Intell. Clin. Pharm , vol.22 , pp. 705-707
    • Maggio, T.G.1    Bartels, D.W.2
  • 55
    • 48949120189 scopus 로고    scopus 로고
    • Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: Results of a controlled clinical trial
    • Galioto, A., et al. Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: results of a controlled clinical trial. Liver Transpl. 14, 1020-1028 (2008
    • (2008) Liver Transpl , vol.14 , pp. 1020-1028
    • Galioto, A.1
  • 56
    • 1642346985 scopus 로고    scopus 로고
    • Hemodynamic effects of amlodipine, bisoprolol, and lisinopril in hypertensive patients after liver transplantation
    • Neal, D., Brown, M., Wilkinson, I., Byrne, C., & Alexander, G. Hemodynamic effects of amlodipine, bisoprolol, and lisinopril in hypertensive patients after liver transplantation. Transplantation 77, 748-750 (2004
    • (2004) Transplantation , vol.77 , pp. 748-750
    • Neal, D.1    Brown, M.2    Wilkinson, I.3    Byrne, C.4    Alexander, G.5
  • 57
    • 81755163663 scopus 로고    scopus 로고
    • Hepatic fibrosis and the renin-Angiotensin system
    • Abbas, G., Silveira, M. G., & Lindor, K. D. Hepatic fibrosis and the renin-Angiotensin system. Am. J. Ther. 18, e202-e208 (2011
    • (2011) Am. J. Ther , vol.18 , pp. e202-e208
    • Abbas, G.1    Silveira, M.G.2    Lindor, K.D.3
  • 58
    • 33645451066 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation
    • Heinze, G., et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J. Am. Soc. Nephrol. 17, 889-899 (2006
    • (2006) J. Am. Soc. Nephrol , vol.17 , pp. 889-899
    • Heinze, G.1
  • 59
    • 84856482663 scopus 로고    scopus 로고
    • Renin-Angiotensin system blockade and kidney transplantation: A longitudinal cohort study
    • Hernandez, D., et al. Renin-Angiotensin system blockade and kidney transplantation: a longitudinal cohort study. Nephrol. Dial. Transplant. 27, 417-422 (2012
    • (2012) Nephrol. Dial. Transplant , vol.27 , pp. 417-422
    • Hernandez, D.1
  • 60
    • 33645834141 scopus 로고    scopus 로고
    • Evaluation of episodes of sleep apnea in patients with liver cirrhosis
    • Ogata, T., Nomura, M., Nakaya, Y., & Ito, S. Evaluation of episodes of sleep apnea in patients with liver cirrhosis. J. Med. Invest. 53, 159-166 (2006
    • (2006) J. Med. Invest , vol.53 , pp. 159-166
    • Ogata, T.1    Nomura, M.2    Nakaya, Y.3    Ito, S.4
  • 61
    • 84928589739 scopus 로고    scopus 로고
    • Evolution of the serum atherogenic risk in liver transplant recipients; Role of lipoproteins, metabolic and inflammatory markers
    • Chhatrala, R., et al. Evolution of the serum atherogenic risk in liver transplant recipients; role of lipoproteins, metabolic and inflammatory markers. Liver Transpl. 21, 623-630 (2015
    • (2015) Liver Transpl , vol.21 , pp. 623-630
    • Chhatrala, R.1
  • 62
    • 84860144206 scopus 로고    scopus 로고
    • American association of clinical endocrinologists guidelines for management of dyslipidemia and prevention of atherosclerosis
    • Jellinger, P., et al. American Association of Clinical Endocrinologists Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr. Pract. 18, 1-78 (2012
    • (2012) Endocr. Pract , vol.18 , pp. 1-78
    • Jellinger, P.1
  • 63
    • 84897970506 scopus 로고    scopus 로고
    • 2013 acc/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American college of cardiology/American Heart Association task force on practice guidelines
    • Stone, N. J., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129, 1-45 (2013
    • (2013) Circulation , vol.129 , pp. 1-45
    • Stone, N.J.1
  • 64
    • 84899810207 scopus 로고    scopus 로고
    • The National Lipid Associations Statin Safety Task F. An assessment by the Statin Liver Safety Task Force: 2014 update
    • Bays, H., Cohen, D. E., Chalasani, N., Harrison, S. A., & The National Lipid Associations Statin Safety Task, F. An assessment by the Statin Liver Safety Task Force: 2014 update. J. Clin. Lipidol. 8, 47-57 (2014
    • (2014) J. Clin. Lipidol , vol.8 , pp. 47-57
    • Bays, H.1    Cohen, D.E.2    Chalasani, N.3    Harrison, S.A.4
  • 65
    • 67649997360 scopus 로고    scopus 로고
    • Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia
    • Almutairi, F., et al. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Liver Transpl. 15, 504-508 (2009
    • (2009) Liver Transpl , vol.15 , pp. 504-508
    • Almutairi, F.1
  • 66
    • 84928814571 scopus 로고    scopus 로고
    • Management of hypertriglyceridemia for prevention of atherosclerotic cardiovascular disease
    • Brinton, E. A. Management of Hypertriglyceridemia for Prevention of Atherosclerotic Cardiovascular Disease. Cardiol. Clin. 33, 309-323 (2015
    • (2015) Cardiol. Clin , vol.33 , pp. 309-323
    • Brinton, E.A.1
  • 67
    • 0035798944 scopus 로고    scopus 로고
    • Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: A follow-up study
    • Leidig-Bruckner, G., et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 357, 342-347 (2001
    • (2001) Lancet , vol.357 , pp. 342-347
    • Leidig-Bruckner, G.1
  • 68
    • 33846183785 scopus 로고    scopus 로고
    • Pamidronate and osteoporosis prevention in liver transplant recipients
    • Pennisi, P., et al. Pamidronate and osteoporosis prevention in liver transplant recipients. Rheumatol. Int. 27, 251-256 (2007
    • (2007) Rheumatol. Int , vol.27 , pp. 251-256
    • Pennisi, P.1
  • 69
    • 2442425472 scopus 로고    scopus 로고
    • Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolism
    • Guichelaar, M. M., Malinchoc, M., Sibonga, J., Clarke, B. L., & Hay, J. E. Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolism. Liver Transpl. 10, 638-647 (2004
    • (2004) Liver Transpl , vol.10 , pp. 638-647
    • Guichelaar, M.M.1    Malinchoc, M.2    Sibonga, J.3    Clarke, B.L.4    Hay, J.E.5
  • 70
    • 82255181447 scopus 로고    scopus 로고
    • Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis-implications for post-Transplantation bone disease
    • Westenfeld, R., et al. Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis-implications for post-Transplantation bone disease. Nephrol. Dial. Transplant. 26, 4115-4123 (2011
    • (2011) Nephrol. Dial. Transplant , vol.26 , pp. 4115-4123
    • Westenfeld, R.1
  • 71
    • 23744480529 scopus 로고    scopus 로고
    • Alendronate in combination with calcium and Vitamin D prevents bone loss after orthotopic liver transplantation: A prospective single-center study
    • Millonig, G., et al. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study. Liver Transpl. 11, 960-966 (2005
    • (2005) Liver Transpl , vol.11 , pp. 960-966
    • Millonig, G.1
  • 72
    • 84858436130 scopus 로고    scopus 로고
    • Early changes in kidney function predict long-Term chronic kidney disease and mortality in patients after liver transplantation
    • Cantarovich, M., et al. Early changes in kidney function predict long-Term chronic kidney disease and mortality in patients after liver transplantation. Transplantation 92, 1358-1363 (2011
    • (2011) Transplantation , vol.92 , pp. 1358-1363
    • Cantarovich, M.1
  • 73
    • 84907277321 scopus 로고    scopus 로고
    • The role of mtor inhibitors in liver transplantation: Reviewing the evidence
    • Klintmalm, G. B., & Nashan, B. The role of mTOR inhibitors in liver transplantation: reviewing the evidence. J. Transplant 2014, 845438 (2014
    • (2014) J. Transplant , vol.2014 , pp. 845438
    • Klintmalm, G.B.1    Nashan, B.2
  • 75
    • 0033662284 scopus 로고    scopus 로고
    • Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-Analysis of epidemiological studies
    • Park-Wyllie, L., et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-Analysis of epidemiological studies. Teratology 62, 385-392 (2000
    • (2000) Teratology , vol.62 , pp. 385-392
    • Park-Wyllie, L.1
  • 76
    • 0030883499 scopus 로고    scopus 로고
    • Pregnancy after liver transplantation under tacrolimus
    • Jain, A., et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 64, 559-565 (1997
    • (1997) Transplantation , vol.64 , pp. 559-565
    • Jain, A.1
  • 77
    • 0028258495 scopus 로고
    • National transplantation pregnancy registry-outcomes of 154 pregnancies in cyclosporine-Treated female kidney transplant recipients
    • Armenti, V. T., et al. National transplantation Pregnancy Registry-outcomes of 154 pregnancies in cyclosporine-Treated female kidney transplant recipients. Transplantation 57, 502-506 (1994
    • (1994) Transplantation , vol.57 , pp. 502-506
    • Armenti, V.T.1
  • 78
    • 0034722936 scopus 로고    scopus 로고
    • Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus
    • Kainz, A., Harabacz, I., Cowlrick, I. S., Gadgil, S. D., & Hagiwara, D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 70, 1718-1721 (2000
    • (2000) Transplantation , vol.70 , pp. 1718-1721
    • Kainz, A.1    Harabacz, I.2    Cowlrick, I.S.3    Gadgil, S.D.4    Hagiwara, D.5
  • 79
    • 84857116422 scopus 로고    scopus 로고
    • Teratogenicity of mycophenolate confirmed in a prospective study of the european network of teratology information services
    • Hoeltzenbein, M., et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am. J. Med. Genet A 158A, 588-596 (2012
    • (2012) Am. J. Med. Genet A , vol.158 A , pp. 588-596
    • Hoeltzenbein, M.1
  • 81
    • 84946498623 scopus 로고    scopus 로고
    • World Health Organization. Medical eligibility criteria for contraceptive use. Fourth Edition [online
    • World Health Organization. Human Reproduction Programme. Medical eligibility criteria for contraceptive use. Fourth Edition [online], http://www.who.int/reproductivehealth/publications/family-planning/Ex-Summ-MEC-5/en/.(2015
    • (2015) Human Reproduction Programme
  • 82
    • 77952979871 scopus 로고    scopus 로고
    • Adaptation of the world health organization s medical eligibility criteria for contraceptive use for use in the United States
    • Curtis, K. M., Jamieson, D. J., Peterson, H. B., & Marchbanks, P. A. Adaptation of the World Health Organizations medical eligibility criteria for contraceptive use for use in the United States. Contraception 82, 3-9 (2010
    • (2010) Contraception , vol.82 , pp. 3-9
    • Curtis, K.M.1    Jamieson, D.J.2    Peterson, H.B.3    Marchbanks, P.A.4
  • 83
    • 77953005326 scopus 로고    scopus 로고
    • Contraceptive use among solid organ transplant patients: A systematic review
    • Paulen, M. E., Folger, S. G., Curtis, K. M., & Jamieson, D. J. Contraceptive use among solid organ transplant patients: a systematic review. Contraception 82, 102-112 (2010
    • (2010) Contraception , vol.82 , pp. 102-112
    • Paulen, M.E.1    Folger, S.G.2    Curtis, K.M.3    Jamieson, D.J.4
  • 84
    • 84946505628 scopus 로고    scopus 로고
    • U.S. Preventive Services Task Force online
    • U.S. Preventive Services Task Force. Strength of evidence grading system [online], http://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions (2012
    • (2012) Strength of Evidence Grading System


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.